[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343150-105":59,"doc-detail-343150-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","bio-inspired-biorthogonal-compartmental-microparticles-for-tumor-chemotherapy-and-photothermal-therapy","Bio-inspired biorthogonal compartmental microparticles for tumor chemotherapy and photothermal therapy","","Microcarrier-based drug delivery can improve cancer treatment, but progress depends on building structures that load agents precisely and release them in a controllable sequence. Inspired by nucleus–cytoplasm structure and material exchange, biorthogonal compartmental microparticles (BCMs) are engineered via microfluidics to separately load and sequentially release TCO-DOX and Tz-ICG. Tz-ICG activates TCO-DOX and functions as a photothermal agent, enabling combined bioorthogonal chemotherapy and photothermal therapy. Cyclooctene modification of DOX reduces systemic toxicity while BCMs show strong in vitro tumor cell eradication and effective tumor growth inhibition with favorable safety, supporting localized prodrug activation platforms for cancer therapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bio-inspired-biorthogonal-compartmental-microparticles-for-tumor-chemotherapy-and-photothermal-therapy/343150/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bio-inspired-biorthogonal-compartmental-microparticles-for-tumor-chemotherapy-and-photothermal-therapy/343150.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How do the biorthogonal compartmental microparticles load and release the therapeutic agents?","Question",{"text":112,"@type":113},"The BCMs are produced by microfluidics to separately load cyclooctene-modified doxorubicin prodrug (TCO-DOX) and tetrazine-modified indocyanine green (Tz-ICG), then release them sequentially for tumor therapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What roles does Tz-ICG play in the treatment strategy?",{"text":117,"@type":113},"Tz-ICG acts as an activator for TCO-DOX and also serves as a photothermal agent, enabling combined bioorthogonal chemotherapy and photothermal therapy (PTT).",{"name":119,"@type":110,"acceptedAnswer":120},"Why does modifying DOX with cyclooctene matter for safety?",{"text":121,"@type":113},"Cyclooctene modification significantly decreases systemic toxicity of DOX, and the resulting BCMs show efficient tumor cell eradication with notable tumor growth inhibition and favorable safety.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343150,1790240464,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Zhang et al. Journal of Nanobiotechnology (2024) 22:498  \n[https://doi.org/10.1186/s12951-024-02778-w](https://doi.org/10.1186/s12951-024-02778-w)  \nJournal of Nanobiotechnology  \n RESEARCH Open Access  \nBio-inspired biorthogonal compartmental microparticles for tumor chemotherapy and photothermal therapy  \nQingfei Zhang1,2, Gaizhen Kuang1,2, Li Wang2, Lu Fan2, Yechao Zhou1, Luoran Shang4*, Yuanjin Zhao1,3* and Weijian Sun1*  \nAbstract  \nMicrocarrier is a promising drug delivery system demonstrating significant value in treating cancers. One  \nof the main goals is to devise microcarriers with ingenious structures and functions to achieve better therapeutic efficacy in tumors. Here, inspired by the nucleus-cytoplasm structure of cells and the material exchange reaction between them, we develop a type of biorthogonal compartmental microparticles (BCMs) from microfluidics that can separately load and sequentially release cyclooctene-modified doxorubicin prodrug (TCO-DOX) and tetrazine-modified indocyanine green (Tz-ICG) for tumor therapy. The Tz-ICG works not only as an activator forTCO-DOX but also asa photothermal agent, allowing for the combination of bioorthogonal chemotherapy and photothermal therapy (PTT) . Besides, the modification of DOX with cyclooctene significantly decreases the systemic toxicity of DOX. Asa result, the developed BCMs demonstrate efficient in vitro tumor cell eradication and exhibit notable tumor growth inhibition with favorable safety. These findings illustrate that the formulated BCMs establish a platform for bioorthogonal prodrug activation and localized delivery, holding significant potential for cancer therapy and related applications. Keywords Microfluidics, Compartmental microparticle, Biorthogonal chemistry, Chemotherapy, Photothermal therapy  \n*Correspondence:  \nLuoran Shang [luoranshang@fudan.edu.cn](luoranshang@fudan.edu.cn)[ ](luoranshang@fudan.edu.cn)Yuanjin Zhao [yjzhao@seu.edu.cn](yjzhao@seu.edu.cn)[ ](yjzhao@seu.edu.cn)Weijian Sun [fame198288@126.com](fame198288@126.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nZhang et al. Journal of Nanobiotechnology (2024) 22:498 Page 2 of 12  \nGraphical Abstract  \nIntroduction  \nCancer is a significant global public health issue that profoundly impacts human lives and well-being [1–3]. Chemotherapy is among the main methods of tumor treatment, which kills cells directly through chemotherapeutic drugs [4, 5]. However, systemic administration of the drugs leads to low tumor accumulation, resulting in suboptimal drug utilization [6, 7]. Besides, chemotherapy is commonly linked to significant toxicity and adverse effects and frequently falls short of achieving an optimal therapeutic outcome via standalone treatment [8, 9]. In recent years, phototherapies, including photothermal (PTT) and","cbCaiajCLNdAvtHS","https://ap.wps.com/l/cbCaiajCLNdAvtHS","pdf",2818166,12,"English","# Abstract\n## Introduction\n## Background and motivation\n## Microfluidic biorthogonal compartmental microparticles","[{\"question\":\"How do the biorthogonal compartmental microparticles load and release the therapeutic agents?\",\"answer\":\"The BCMs are produced by microfluidics to separately load cyclooctene-modified doxorubicin prodrug (TCO-DOX) and tetrazine-modified indocyanine green (Tz-ICG), then release them sequentially for tumor therapy.\"},{\"question\":\"What roles does Tz-ICG play in the treatment strategy?\",\"answer\":\"Tz-ICG acts as an activator for TCO-DOX and also serves as a photothermal agent, enabling combined bioorthogonal chemotherapy and photothermal therapy (PTT).\"},{\"question\":\"Why does modifying DOX with cyclooctene matter for safety?\",\"answer\":\"Cyclooctene modification significantly decreases systemic toxicity of DOX, and the resulting BCMs show efficient tumor cell eradication with notable tumor growth inhibition and favorable safety.\"}]","Bio-inspired biorthogonal compartmental microparticles for tumor chemotherapy and photothermal therapy | PDF",1790050116,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b953e11d973978e0e67c5060c2ccf40b.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba74944f9bf0caa6e838189872b62a2c.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73f4a69167082b11d97eee4a68ed3e1f.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e46227ce1225883109419cfb2627263.webp",980,1301]